Will Mediclinic break support, or will it rise again to 341p?

• 296-341p range since December; Now trading 304p (at time of writing)
• Will the pattern repeat itself, shares testing 341p highs?
• Shares -57.4% from 2018 highs; +3.6% from 2019 lows; -5.7% year-to-date
• 7 Jan: JP Morgan says Mediclinic attractive, upgrades to overweight
• Source: Dow Jones, Bloomberg, FT, Company News, AlphaTerminal

Click to enlarge

Trading Mediclinic – An Example

Let’s say you like the range, you think it’s heading back towards 341p again. You decide to Buy exposure to £10,000 worth of Mediclinic  using a CFD, at the current price of 304p. To do this, you need £2,000.

Let’s assume Mediclinic rises back to range ceiling at 341p (+12.2%). Your profit would be £1220, from your initial investment of £2,000.

Conversely, let’s assume you open the above position, and place a stop-loss at 5% from the current price. Mediclinic falls 5% and hits your stop-loss. Your loss would be £500.

This is provided for information purposes only. It should not be taken as a recommendation.